Tenaya Therapeutics

TNYA

Market cap $167M

TNYA Hedge Fund Activity: Q1 2026 in Review

103 of the 8,131 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q1 2026, worth a combined $37.5M — down 23% from $48.8M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new TNYA positions and 19 closed out — a net gain of 7 holders — while 32 added to existing stakes and 18 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.37M. The largest seller was Column Group, exiting entirely with an estimated $6.69M sold.

• 103 institutional investors held Tenaya Therapeutics (TNYA) as of Q1 2026, up from 97 in Q4 2025.
• Funds reported $37.5M of Tenaya Therapeutics stock for Q1 2026, down 23% quarter-over-quarter.
• 26 funds opened new Tenaya Therapeutics positions in Q1 2026 and 19 closed out, a net change of +7 holders.
• The largest Tenaya Therapeutics buyer in Q1 2026 was Renaissance Technologies, an estimated $1.37M added.
• The largest Tenaya Therapeutics seller in Q1 2026 was Column Group, an estimated $6.69M sold.

Based on aggregated 13F filings for Q1 2026.